HAMILTON, ON, Jan. 5, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (FUSN), and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (BWXT), today announced that the companies have entered ...

Collaboration enables Fusion to produce high purity actinium-225 at Company's GMP manufacturing facility Agreement furthers BWXT Medical's position as a global leader in medical isotope supply Under ...

Seaport Global analyst Jeff Campbell on Tuesday initiated coverage on BWX Technologies Inc (NYSE:BWXT) with a Buy rating and a price target of $145. Campbell noted BWX Technologies’ multidecade U.S.

BWX Technologies Inc. announced Tuesday plans to acquire a company in the growing medical radioisotope market. The Lynchburg-based manufacturer of nuclear components said it had reached an agreement ...

Romania's Nuclearelectrica corporation is advancing the development of nuclear medicine in Europe under an innovative agreement with BWXT Medical Ltd., part of BWX Technologies, Inc., the company ...

BWX Technologies has announced the appointment of Thomas Burns Jr. as president and program manager for the BWXT-led Savannah River Mission Completion joint venture. Burns, who currently serves as ...

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today announced that it has entered into an agreement to acquire Kinectrics, Inc., for approximately US$525 million, including ...

Revenue (GAAP) reached $764.0 million for Q2 2025, exceeding the $711.1 million GAAP estimate and up 12% compared to Q2 2024. Non-GAAP EPS was $1.02 for Q2 2025, above the $0.79 non-GAAP estimate and ...

BWX Technologies, Inc. BWXT is scheduled to report fourth-quarter 2024 results after market close on Feb. 24. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks ...